Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition?

被引:47
作者
Schmid, Maximilian P. [1 ]
Nesvacil, Nicole [1 ]
Poetter, Richard [1 ,2 ]
Kronreif, Gernot [3 ]
Kirisits, Christian [1 ,2 ]
机构
[1] Med Univ Vienna, Dept Radiat Oncol, Ctr Comprehens Canc, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
[2] Med Univ Vienna, Christian Doppler Lab Med Radiat Res Radiat Oncol, Vienna, Austria
[3] ACMIT, Wiener Neustadt, Austria
关键词
Cervix cancer; Radiotherapy; Image-guided adaptive brachytherapy; MRI; Transrectal ultrasound; INTERSTITIAL BRACHYTHERAPY; CLINICAL FEASIBILITY; COMPUTED-TOMOGRAPHY; TUMOR DELINEATION; VOLUME; APPLICATOR; PARAMETERS; CARCINOMA; IMPACT; INTRACAVITARY;
D O I
10.1016/j.radonc.2016.01.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To compare the maximum high risk clinical target volume (CTVHR) dimensions and image quality between magnetic resonance imaging (MRI), transrectal ultrasound (TRUS) and computed tomography (CT) in image guided adaptive brachytherapy (IGABT) of locally advanced cervical cancer. Material and methods: All patients with locally advanced cervical cancer treated with radiochemotherapy and IGABT between 09/2012-05/2013 were included in this study. T2-weighted MRI (1.5 tesla), TRUS and CT were performed before (MRIpreBT, TRUSpreBT) and/or after (MRIBT, TRUSBT and CTBT) insertion of the applicator. 3D TRUS image acquisition was done with a customized US stepper device and software. The HR CTV was defined on 3D image sequences acquired with different imaging modalities by one blinded observer, in accordance to the GEC-ESTRO recommendations for MRI-based target volume delineation, as the complete cervical mass including the tumour, any suspicious areas of parametrial involvement and the normal cervical stroma. Maximum HR CTV width and thickness were measured on transversal planes. Image quality was classified using the following scoring system: Grade 0: not depicted, Grade 1: inability to discriminate, margin not recognizable, Grade 2: fair discrimination, margin indistinct, Grade 3: excellent discrimination, margin distinct. Descriptive statistics, mean differences between the groups, with MRIBT as reference, and a paired t-test were calculated. Results: Images from 19 patients (FIGO IB: 3, IIB: 9, IIIB: 5, IVB: 2) were available for analysis. The mean difference in maximum HR CTV width of TRUSBT, TRUSpreBT, MRIpreBT, CTBT to MRIBT was 0.0 mm +/- 4.7 (n.s.), -1.1 mm +/- 5.6 (n.s.), 0.7 mm +/- 6.4 (n.s.) and 13.8 mm +/- 6.7 (p < 0.001). The mean difference in maximum HR CTV thickness of TRUSBT, TRUSpreBT, MRIpreBT, CTBT to MRIBT was -3.4 mm +/- 5.9 (p = 0.037), -3.4 mm +/- 4.2 (p < 0.001), 2.0 mm +/- 6.1 (n.s.) and 13.9 mm +/- 6.3 (p < 0.001). Mean scores of image quality of the target volume was 2.9 for TRUSpreBT, 2.3 for TRUSBT, 2.9 for MRIpreBT, 2.7 for MRIBT and 2.1 for CTBT. Conclusion: For the assessment of the HR CTV in IGA(BT) of cervical cancer, TRUS is within the intraobserver variability of MRI. TRUS is superior to CT as it yields systematically smaller deviations from MRI, with good to excellent image quality. Small differences of TRUS HR CTV thickness are likely related to differences in image slice orientation and compression of the cervix by the TRUS probe before insertion of the brachytherapy applicator. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:467 / 472
页数:6
相关论文
共 30 条
  • [1] Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: Results of the French STIC prospective study
    Charra-Brunaud, Claire
    Harter, Valentin
    Delannes, Martine
    Haie-Meder, Christine
    Quetin, Philippe
    Kerr, Christine
    Castelain, Bernard
    Thomas, Laurence
    Peiffert, Didier
    [J]. RADIOTHERAPY AND ONCOLOGY, 2012, 103 (03) : 305 - 313
  • [2] Systematic evaluation of MRI findings in different stages of treatment of cervical cancer:: Potential of MRI on delineation of target, pathoanatomic structures, and organs at risk
    Dimopoulos, JCA
    Schard, G
    Berger, D
    Lang, S
    Goldner, G
    Helbich, T
    Pötter, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (05): : 1380 - 1388
  • [3] The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer:: Clinical feasibility and preliminary results
    Dimopoulos, Johannes C. A.
    Kirisits, Christian
    Petric, Primoz
    Georg, Petra
    Lang, Stefan
    Berger, Daniel
    Poetter, Richard
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (01): : 83 - 90
  • [4] Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy
    Dimopoulos, Johannes C. A.
    Petrow, Peter
    Tanderup, Kari
    Petric, Primoz
    Berger, Daniel
    Kirisits, Christian
    Pedersen, Erik M.
    van Limbergen, Erik
    Haie-Meder, Christine
    Poetter, Richard
    [J]. RADIOTHERAPY AND ONCOLOGY, 2012, 103 (01) : 113 - 122
  • [5] Early-stage cervical cancer: Tumor delineation by magnetic resonance imaging and ultrasound - A European multicenter trial
    Epstein, Elisabeth
    Testa, Antonia
    Gaurilcikas, Adrius
    Di Legge, Alessia
    Ameye, Liveke
    Atstupenaite, Vaida
    Valentini, Anna Lia
    Gui, Benedetta
    Wallengren, Nils-Olof
    Pudaric, Sonja
    Cizauskas, Arvydas
    Masback, Anna
    Zannoni, Gian Franco
    Kannisto, Paivi
    Zikan, Michal
    Pinkavova, Ivana
    Burgetova, Andrea
    Dundr, Pavel
    Nemejcova, Kristyna
    Cibula, David
    Fischerova, Daniela
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 128 (03) : 449 - 453
  • [6] Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component
    Fokdal, Lars
    Tanderup, Kari
    Hokland, Steffen Bjerre
    Rohl, Lisbeth
    Pedersen, Erik Morre
    Nielsen, Soren Kynde
    Paludan, Merete
    Lindegaard, Jacob Christian
    [J]. RADIOTHERAPY AND ONCOLOGY, 2013, 107 (01) : 63 - 68
  • [7] Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group* (I):: concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV
    Haie-Meder, C
    Pötter, R
    Van Limbergen, E
    Briot, E
    De Brabandere, M
    Dimopoulos, J
    Dumas, I
    Hellebust, TP
    Kirisits, C
    Lang, SF
    Muschitz, S
    Nevinson, J
    Nulens, A
    Petrow, P
    Wachter-Gerstner, N
    [J]. RADIOTHERAPY AND ONCOLOGY, 2005, 74 (03) : 235 - 245
  • [8] High-risk clinical target volume delineation in CT-guided cervical cancer brachytherapy: Impact of information from FIGO stage with or without systematic inclusion of 3D documentation of clinical gynecological examination
    Hegazy, Neamat
    Poetter, Richard
    Kirisits, Christian
    Berger, Daniel
    Federico, Mario
    Sturdza, Alina
    Nesvacil, Nicole
    [J]. ACTA ONCOLOGICA, 2013, 52 (07) : 1345 - 1352
  • [9] Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer
    Kirisits, C
    Pötter, R
    Lang, S
    Dimopoulos, J
    Wachter-Gerstner, N
    Georg, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (03): : 901 - 911
  • [10] MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective
    Lindegaard, Jacob Christian
    Fokdal, Lars Ulrik
    Nielsen, Soren Kynde
    Juul-Christensen, Jens
    Tanderup, Kari
    [J]. ACTA ONCOLOGICA, 2013, 52 (07) : 1510 - 1519